The George Institute China

The George Institute China is a leading independent medical research institute focused on addressing the growing burden of non-communicable diseases in China. Established in 2004 through a partnership with Peking University Health Science Center, the institute conducts large-scale clinical trials, epidemiological studies, and health systems research. Its primary focus areas include cardiovascular disease, stroke, diabetes, and kidney disease, with a particular emphasis on low-cost, high-impact interventions like salt substitution. The institute works closely with government agencies and healthcare providers to translate research findings into national health policy and clinical practice. By leveraging global expertise and local partnerships, it aims to improve health outcomes for millions of people across the region.